No. Prevnar 20 is not indicated to help protect against viruses, including COVID-19. Prevnar 20 is indicated to help protect against 20 types of the bacteria Streptococcus pneumoniae. 

The National Advisory Committee on Immunization (NACI) recommends that Prevnar 20 should be offered for individuals who have no previous pneumococcal vaccine immunization or are unaware of their immunization history and are:

For residents of Quebec, the Comité sur l’immunisation du Quebec (CIQ) recommends the implementation of a vaccination program with Prevnar 20 for adults:

From now on, the use of Prevnar 20 should be encouraged for adults who want to protect themselves. 

Ask your doctor, nurse, or pharmacist if Prevnar 20 is right for you.

Individuals at higher risk of pneumococcal infection, including patients with sickle cell disease or human immunodeficiency virus (HIV) infection, and those previously vaccinated with one or more doses of the 23-valent pneumococcal polysaccharide vaccine (PPSV23), are recommended to receive at least one dose of Prevnar 20.  

If the sequential use of PPSV23 is considered appropriate, Prevnar 20 should be given first.

The National Advisory Committee on Immunization (NACI) recommends that Prevnar 20 should be offered for adults ≥65 years of age if it has been at least five years from the last dose of a previous pneumococcal vaccine (PNEU-P-23).

For residents of Quebec, the Comité sur l’immunisation du Quebec (CIQ) recommends that Prevnar 20 may be offered for adults ≥1 year after previous immunization with PNEU-P-23.

PNEU-P-23: Pneumovax 23

Talk to your doctor, nurse, or pharmacist to discuss your options and see if Prevnar 20 is right for you. 

Prevnar 20 is to be administered as one dose to adults 18 years and older. If the combination of Prevnar 20 and PNEU-P-23 vaccine is appropriate, Prevnar 20 should be given first. 

PNEU-P-23: Pneumovax 23

Yes. Side effects include headache, joint/muscle pain, pain/tenderness at the injection site, fatigue, swelling/redness at the injection site, fever, allergic reactions (including swelling, shortness of breath, wheezing), diarrhea, nausea, vomiting, rash and swelling of the face/lips/mouth/tongue/throat which may cause difficulty in swallowing or breathing, itching/hives at the injection site, swollen glands in the neck/armpit/groin, and chills. Severe allergic reaction, shock, or cardiovascular collapse were seen with Prevnar 13 and may also be seen with Prevnar 20. These are not all the possible side effects you may have when receiving Prevnar 20. If you experience any side effects not listed here, tell your healthcare professional. 

Study results have indicated that you may be at increased risk of pneumococcal disease if you are aged 50+, or 18+ living with immunocompromising conditions or taking medications that suppress your immune system, or have one of the following risk factors: diabetes, chronic heart disease, smoking, cancer, chronic liver disease, alcoholism, certain neurological conditions, and/or living in long-term care facilities. Take the Risk Factor Quiz

Pneumococcal disease is any infection caused by the bacteria Streptococcus pneumoniae, including pneumonia (lung infection), bacteraemic pneumonia (lung infection with bacteria in the bloodstream), sepsis (bacteria in bloodstream), and meningitis (inflammation around the brain).

Like the flu, the bacteria causing pneumococcal disease (Streptococcus pneumoniae) can be passed on from person to person through 
talking, coughing, and sneezing.